Intervention
Adavosertib
ClinicalTrials.gov intervention label
Clinical trials
2 shownProstate Cancer Biomarker Enrichment and Treatment SelectionNCT03385655 · 2018-08-01
ACTIVE_NOT_RECRUITINGTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17
ACTIVE_NOT_RECRUITINGCommon conditions
Advanced Lymphoma1Advanced Malignant Solid Neoplasm1Bladder Carcinoma1Breast Carcinoma1Cervical Carcinoma1Colon Carcinoma1Colorectal Carcinoma1Endometrial Carcinoma1Esophageal Carcinoma1Exocrine Pancreas Carcinoma1Gastric Carcinoma1Glioma1Head and Neck Carcinoma1Hematopoietic and Lymphoid Cell Neoplasm1Kidney Carcinoma1Liver Carcinoma1Lung Carcinoma1Lymphoma1Malignant Uterine Corpus Neoplasm1Malignant Uterine Neoplasm1Melanoma1Multiple Myeloma1Ovarian Carcinoma1Prostate Cancer1Prostate Carcinoma1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING2
Phase mix
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.